DRREDDY:NSE
Dr Reddy's Laboratories Ltd
₹1,199.80
arrow_upward
+1.68%(+19.80) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRREDDY...
Open
₹1,180.00
High
₹1,200.80
Low
₹1,172.00
Mkt. cap
997.09B
Avg. vol.
1.81M
Volume
1.51M
Dividend
0.67%
Quarterly dividend
₹2.00
Ex-dividend date
Jul 10, 2026
P/E ratio
31.03
52-wk high
₹1,414.90
52-wk low
₹1,101.00
EPS
₹38.67
Shares outstanding
166.06M
No. of employees
28K
Open
₹1,180.00
High
₹1,200.80
Low
₹1,172.00
Mkt. cap
997.09B
Avg. vol.
1.81M
Volume
1.51M
Dividend
0.67%
Quarterly dividend
₹2.00
Ex-dividend date
Jul 10, 2026
P/E ratio
31.03
52-wk high
₹1,414.90
52-wk low
₹1,101.00
EPS
₹38.67
Shares outstanding
166.06M
No. of employees
28K
News stories
From web sources and news partners
AOL.com
·
29 minutes ago
Vanguard's S&P 500 Index Fund Charges About $3 a Year on $10,000. The Average Stock Fund Charges About $40.
JournalArta
·
4 hours ago
Stock Market Week Ahead: What to Know
ChartMill
·
1 day ago
Friday's session: top gainers and losers in the dow jones index
Proactive financial news
·
1 day ago
Frank Talk: Gold miners beat every S&P 500 sector in Q3 despite September selloff
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
About Dr Reddy's Laboratories Ltd
CEOErez Israeli
Employees27.5K
Founded1984
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websitedrreddys.com